Bio-Techne Corp · LS:A12ENG

Bio-Techne Corp financial statements

Bio-Techne Corp's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue1.22B1.22B1.16B1.14B1.11B931.0M738.7M714.0M643.0M563.0M
Cost of revenue416.0M429.4M389.3M366.9M349.1M298.2M255.5M240.5M210.8M188.5M
Gross profit799.1M790.3M769.7M769.8M756.5M632.9M483.2M473.5M432.1M374.5M
Research and development94.8M99.5M96.7M92.5M87.1M70.6M65.2M62.4M55.3M53.5M
Selling, general and administrative452.4M588.5M466.4M378.4M372.8M325.0M260.6M264.4M240.6M200.4M
Operating income251.9M102.3M206.7M298.9M296.6M237.3M157.4M146.7M136.2M120.6M
Depreciation and amortization97.4M109.9M111.7M107.2M101.1M87.7M82.7M78.2M64.5M60.0M
EBITDA349.2M212.2M318.4M406.2M397.7M325.0M240.2M224.9M200.6M180.6M
Interest expense9.63M8.51M15.7M11.2M11.3M14.0M19.2M21.7M10.2M7.36M
Income before tax240.7M98.5M185.7M338.7M301.4M148.2M276.5M112.0M126.0M112.0M
Income tax58.8M25.1M17.6M53.2M38.3M8.59M47.2M15.9M-198.0K35.9M
Net income181.8M73.4M168.1M285.3M272.1M140.4M229.3M96.1M126.2M76.1M
Earnings per share, basic1.170.471.071.811.730.916.002.543.362.04
Earnings per share, diluted1.160.461.051.761.660.875.822.473.312.03

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents264.7M162.2M151.8M180.6M172.6M199.1M146.6M100.9M122.0M91.6M
Short-term investments01.07M23.7M74.5M32.5M124.3M65.1M59.8M66.1M
Receivables216.6M206.9M241.4M218.5M194.5M145.4M122.5M137.5M120.3M116.8M
Inventory195.7M189.4M179.7M171.6M141.1M116.7M103.2M91.0M85.6M85.6M
Current assets744.4M608.3M617.4M621.5M605.6M510.6M520.9M412.6M398.4M348.0M
Property, plant and equipment231.8M245.7M251.2M226.2M223.2M207.9M176.8M154.0M145.3M135.1M
Goodwill975.4M980.9M972.7M872.7M822.1M843.1M728.3M732.7M597.9M579.0M
Total assets2.59B2.56B2.70B2.64B2.29B2.26B2.03B1.88B1.59B1.56B
Accounts payable26.7M25.3M38.0M25.7M33.9M29.4M23.1M16.2M18.5M16.9M
Current liabilities163.7M175.8M159.4M128.5M176.0M152.3M106.7M102.0M79.5M135.5M
Long-term debt200.0M346.0M319.0M350.0M243.4M328.8M344.2M492.7M339.0M343.8M
Total debt289.1M444.1M419.5M455.0M12.5M12.5M12.5M12.5M347.9M349.9M
Total liabilities478.5M639.1M635.0M672.2M593.8M691.7M646.4M718.8M514.1M605.8M
Shareholders' equity2.11B1.92B2.07B1.97B1.70B1.56B1.38B1.17B1.08B949.6M
Shares outstanding156.1M155.0M158.2M157.6M156.6M39.0M38.5M37.9M37.6M37.4M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations292.1M287.6M299.0M254.4M325.3M352.2M205.2M181.6M170.4M143.7M
Capital spending-28.9M-31.0M-62.9M-38.2M-44.9M-44.3M-51.7M-25.4M-20.9M-15.2M
Free cash flow263.2M256.6M236.1M216.1M280.4M307.9M153.5M156.2M149.4M128.5M
Cash from investing-18.2M-35.2M-203.0M-265.6M-96.9M-243.5M27.1M-336.8M-38.7M-306.0M
Cash from financing-169.1M-253.9M-122.4M22.6M-242.9M-62.6M-183.8M134.4M-99.2M189.1M
Dividends paid-49.9M-50.4M-50.4M-50.3M-50.2M-49.6M-48.9M-48.4M-48.0M-47.3M
Share buybacks-41.7M-275.7M-80.0M-19.6M-160.9M-43.2M-50.1M-15.4M05.26M
Change in cash102.5M10.4M-28.8M8.00M-26.5M52.5M45.7M-21.1M30.4M27.4M